Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... KSP inhibitor, in patients with solid tumors and two Phase 1/2 trials in patients with acute myelogenous leukemia and multiple myeloma. ARRY-614 - p38/Tie-2 Inhibitor for MDS: Array is dosing patients ...
2009 OCT 5 ... cellular telephone use and other factors to the etiology of the disease; 180 cases (87 acute myeloblastic leukemia, 40 acute lymphoblastic leukemia, 44 chronic myelogenousleukemia, ...
2009 NOV 2 ... 5. Chromosome Analysis a. Chronic MyelogenousLeukemia (CML) b. Acute Myeloid Leukemia (AML) c. Acute Lymphoblastic Leukemia (ALL) d. Malignant Lymphomas ...
2009 OCT 5 ... 'Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells,' is now available. "An elevated serum level of NM23-H1 protein is found in ...
2009 NOV 9 ... been investigated as a potential therapeutic option to improve outcome in patients with acute myelogenous leukemia (AML). However, its optimal role in treatment for adults in remission has not been ...
2009 NOV 16 ... and reverse transcription-PCR demonstrated expression of IGF1R and IR isoform A in acute myelogenous leukemia (AML) cell lines as well as in >80% of clinical AML isolates," scientists writing in ...
2009 NOV 9 ... myelogenous leukemia (CML) or myelodysplastic syndromes (MDS), or autologous HCT for acute myelogenous leukemia (AML) or lymphoma in Australia or New Zealand between 1992 and 2001, recorded on the ...
2009 SEP 28 ... that a high serum cyclosporine A (CsA) level could result in a lower incidence of acute-graft-versus-host disease (aGVHD). An elevated serum lactate dehydrogenase (LDH) level ... who received allogeneic SCT from an HLA-matched sibling donor for acute and chronic myelogenousleukemia. Univariate analysis showed that two factors (the serum CsA level at the third ...
2009 NOV 16 ... in the journal Transplant Infectious Disease, "We describe a woman with relapsed acute myelogenous leukemia after allogeneic stem cell transplantation who developed disseminated Geotrichum ...
2009 NOV 27 ... Tc-99m for diagnostics, I-131 for non-Hodgkin's lymphoma and thyroid cancer, Ac-225 for acute myelogenous leukemia, and Cu-67 for lymphoma cancer," wrote G.L. Troyer and colleagues.The ...
2009 SEP 28 ... T cells was accomplished with a peptide/MHC tetramer library. Patients with acute myelogenous leukemia or chronic myelogenous leukemia in remission following HSCT exhibited significant ...
2009 NOV 2 ... the United States, "Acute promyelocytic leukemia (APL) is a relatively rare form of acute myelogenous leukemia (AML). In the United States, APL in children constitutes only 5% to 10% of AML." ...
2009 OCT 5 ... "An elevated serum level of NM23-H1 protein is found in acute myelogenous leukemia (AML) and predicts a poor treatment outcome for AML patients. To investigate the ...
2009 OCT 12 ... bone marrow (BM) cells have previously been done. In this study, BM of three secondary acute myelogenous leukemia (AML) cases with trisomy 8 and otherwise normal karyotype were evaluated. Bone marrow ...
2009 OCT 12 ... of methicillin-resistant Staphylococcus aureus (MRSA)-pyomyositis in association with acute myelogenous leukemia (AML) is reported. MRSA-sepsis developed in a 51-year-old Japanese man with AML, during ...
2009 NOV 2 ... According to recent research from Hamburg, Germany, "Acute myelogenous leukemia is driven by leukemic stem cells (LSCs) generated by mutations that confer (or maintain) ...
2009 NOV 9 ... "Acutemyelogenous leukemias (AMLs) are characterized by medullary and extramedullary invasion. ... and extramedullary invasion. We hypothesized that a supramolecular complex, the leukemia-cell invadosome, which contains certain integrins, matrix metalloproteinases (MMPs), and ...
2009 NOV 9 ... identified and pointed out to three conserved transcription factor binding sites for acute myelogenous leukemia-1 (AML-1), FREAC-4 and Sox17," wrote C. Schmitt and colleagues, INSERM. ...
2009 OCT 12 ... kinase (MEK)/ERK pathway was shown to be constitutively activated in a large number of acute myelogenous leukemia (AML) cells, suggesting the important roles of this pro-survival signaling in ...
